Is Pfizer Stock a Bargain for Long-Term Investors? - Yahoo Finance

Nov 4, 2024  · In fact, several high-yield dividend stocks have outperformed the S&P 500 in 2024. This environment makes Pfizer 's (NYSE: PFE) hefty 5.9% dividend yield and rock-bottom valuation especially ...


Install CouponFollow Chrome Extension   CouponFollow Extension

9%
OFF

Is Pfizer Stock A Bargain For Long-Term Investors? - Yahoo Finance

1 week from now

Nov 4, 2024  · In fact, several high-yield dividend stocks have outperformed the S&P 500 in 2024. This environment makes Pfizer 's (NYSE: PFE) hefty 5.9% dividend yield and rock-bottom valuation especially ...

yahoo.com

$2.45
OFF

Buy, Sell Or Hold Pfizer Stock After Q3 Earnings Beat, Guidance …

1 week from now

Nov 4, 2024  · Adjusted earnings guidance was raised from $2.45 to $2.65 per share to a range of $2.75 to $2.95. The total revenue guidance range was upped from $59.5 billion to $62.5 billion …

yahoo.com

32%
OFF

Is Pfizer Stock Still A Buy After An Unexpected Setback? - Yahoo …

1 week from now

Aug 26, 2024  · PFE. With Pfizer(NYSE: PFE) stock badly underperforming the market over the past three years, falling by 32% while the market rose by close to the same amount, the last …

yahoo.com

$56
OFF

Could Pfizer Be A No-Brainer Stock To Buy Right Now ... - Yahoo …

1 week from now

Dec 28, 2023  · It wasn't long ago that the two products generated combined sales of more than $56.7 billion. Pfizer expects its total COVID sales to be only around $12.5 billion in 2023. Data …

yahoo.com

9%
OFF

Could Pfizer Be A No-Brainer Stock To Buy Right Now, Even If Its …

1 week from now

Dec 28, 2023  · On the other hand, I think that Pfizer is a no-brainer stock to buy right now for two types of investors. Income investors should love the company's dividend yield of over 5.9%.

fool.com

420%
OFF

Pfizer Inc. (PFE) Is A Trending Stock: Facts To Know Before Betting …

1 week from now

2 days ago  · Pfizer is expected to post earnings of $0.52 per share for the current quarter, representing a year-over-year change of +420%. Over the last 30 days, the Zacks Consensus …

yahoo.com

10%
OFF

3 Stocks Seeing Insider Buys: CNC, PFE, BMY - Yahoo Finance

1 week from now

4 days ago  · Investors closely monitor insider buys, as they can give hints surrounding the long-term picture. An insider is an officer, director, 10% stockholder, or anyone who possesses …

yahoo.com

9%
OFF

Is Pfizer Stock A Bargain For Long-Term Investors?

1 week from now

Nov 4, 2024  · Pfizer's stock, trading at a low valuation with a 5.9% dividend yield, is attracting long-term investors as the Federal Reserve's rate cuts shift sentiment towards dividend-paying …

longportapp.com

$15
OFF

I’m An Investor: My First Stock Ever — And Why I Still Have It

1 week from now

2 hours ago  · Apple was also the first stock purchase by JJ Maxwell, CEO at Double Finance, who acquired shares in the early 2000s, for about $15 a share. “I bought Apple because I was …

yahoo.com

$500
OFF

Have $500? 3 Absurdly Cheap Stocks Long-Term Investors

1 week from now

1 day ago  · As such, this is great, cheap growth stock to buy. The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now…

yahoo.com

10%
OFF

Energy Stocks Have Soared This Year, But, These 3 Still ... - Yahoo …

1 week from now

4 hours ago  · Most sectors have rallied, including energy. The average energy stock in the S&P 500 is up more than 10% this year. Despite that rally, several energy stocks still look like …

yahoo.com

$40.88
OFF

Key Takeaways From Pfizer Analyst Ratings - Benzinga

1 week from now

2 days ago  · Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $40.88, with a high estimate of $45.00 and a low estimate of $25.00. This …

benzinga.com

$1000
OFF

My Favorite Hypergrowth Stock To Buy With $1,000 Right Now

1 week from now

1 day ago  · Companies capable of hypergrowth often see their stock prices bid up to outrageous levels. Often, however, shares remain a bargain compared to their long-term potential. Since …

yahoo.com

FAQs about Is Pfizer Stock a Bargain for Long-Term Investors? - Yahoo Finance Coupon?

Is Pfizer stock a good long-term investment?

It's time to get the word out: The pessimism on Pfizer stock has gone too far. At first glance, Pfizer looks like a money pit, but the stock is more of a table-pounding bargain. Here are three reasons investors should consider snapping up Pfizer as a long-term investment with market-beating potential. 1. This 6% dividend yield is no trap ...

Is Pfizer's stock a buy?

Pfizer's Stock Is a Buy. Here Are Six Reasons Why. Pfizer may be one of the biggest bargains in the market today. The drugmaker offers an attractive yield, a rock-bottom valuation, and an underappreciated cancer pipeline. Long-term investors shouldn't hesitate to add this top dividend stock to their portfolios right now. ...

Should you buy Pfizer (PFE) stock?

Pfizer's stock is a buy, with six reasons why. Pfizer (NYSE: PFE) stock is an investing enigma. Trading at around 11 times forward earnings, the drugmaker's shares have printed fresh 52-week lows consistently over the past two years, putting its stock in serious bargain territory. ...

Is Pfizer a top Buy Right Now?

As rate cuts continue to drive a rotation into high-yielding dividend stocks with compelling valuations, this high-yielding pharmaceutical leader scans as a top buy right now. That said, Pfizer's transformation is far from over, with several important challenges, such as its upcoming patent cliff, remaining firmly in view. ...

Is Pfizer a good dividend stock?

Pfizer has long been a dividend-paying stock and built a solid reputation by raising it for 14 consecutive years. Today, the dividend yield stands out more than the company's growth. Its current 6% yield is the highest outside of the financial crisis in 2008-2009. ...

Is Pfizer a good stock to buy in 2025?

Pfizer’s new products/late-stage pipeline candidates and newly acquired products, including those acquired from Seagen, position it strongly for operational growth in 2025 and beyond. Pfizer expects 2025 to 2030 revenue CAGR to be approximately 6%. Those who own Pfizer's stock may stay invested to see how Pfizer's new growth drivers perform. ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension